TBRG · Insider Trading
TruBridge, Inc. Common Stock
Every open-market purchase and sale reported by TBRG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Regina M. Benjamin | Director | D | −38,687 | −$1.02M |
| 2026-07-10 | L6 Holdings Inc. | 10%+ Owner | U | −5,960,000 | −$156.45M |
| 2026-07-10 | Mark V Anquillare | Director | D | −21,554 | −$565.79K |
| 2026-07-10 | David A Dye | Director | MIXED | −130,436 | −$3.43M |
| 2026-07-10 | Christopher T Hjelm | Director | D | −31,591 | −$829.26K |
| 2026-07-10 | Damien Leonard | Director | D | −2,980,000 | −$78.22M |
| 2026-07-10 | Christopher L Fowler | President and CEO | D | −136,788 | −$3.16M |
| 2026-07-10 | Kevin Plessner | General Counsel | D | −14,610 | −$327.07K |
| 2026-07-10 | Andris Upitis | Director | D | −1,118,554 | −$29.36M |
| 2026-07-10 | David Harse | General Manager Patient Care | D | −21,091 | −$443.31K |
| 2026-07-10 | Vita MacIntyre | Controller | D | −2,687 | −$50.77K |
| 2026-07-10 | Glenn Tobin | Director | D | −50,687 | −$1.33M |
| 2026-07-10 | Michael Daughton | Chief Business Officer | D | −68,064 | −$1.56M |
| 2026-07-10 | Vinay Bassi | Chief Financial Officer | D | −50,499 | −$1.05M |
| 2026-07-10 | Merideth Wilson | Financial Health GM | D | −12,042 | −$203.02K |
| 2026-07-10 | Amy K O'Keefe | Director | D | −7,561 | −$198.48K |
| 2026-07-10 | Jerry G Canada Jr. | Director | D | −4,376 | −$114.87K |
| 2026-04-09 | Kevin Plessner | General Counsel | A | +2,598 | — |
| 2026-04-09 | Vita MacIntyre | Controller | A | +909 | — |
| 2026-04-09 | Christopher L Fowler | President and CEO | A | +19,683 | — |
| 2026-04-09 | David Harse | General Manager Patient Care | A | +5,079 | — |
| 2026-04-09 | Vinay Bassi | Chief Financial Officer | A | +12,698 | — |
| 2026-04-09 | Merideth Wilson | Financial Health GM | A | +5,206 | — |
| 2026-04-09 | Michael Daughton | Chief Business Officer | A | +10,572 | — |
| 2026-03-30 | Vita MacIntyre | Controller | F | −187 | −$2.63K |
| 2026-03-17 | Vita MacIntyre | Controller | F | −125 | −$2.16K |
| 2026-03-17 | Merideth Wilson | Financial Health GM | F | −604 | −$10.46K |
| 2026-03-17 | David Harse | General Manager Patient Care | F | −1,669 | −$29.20K |
| 2026-03-17 | Vinay Bassi | Chief Financial Officer | F | −5,723 | −$100.18K |
| 2026-03-17 | Kevin Plessner | General Counsel | F | −1,165 | −$20.40K |
| 2026-03-17 | Christopher L Fowler | President and CEO | F | −8,122 | −$142.25K |
| 2026-03-17 | David A Dye | Director | F | −4,078 | −$71.37K |
| 2026-03-11 | Kevin Plessner | General Counsel | F | −280 | −$5.17K |
| 2026-03-11 | Christopher L Fowler | President and CEO | F | −2,093 | −$38.66K |
| 2026-03-11 | David A Dye | Director | MIXED | −10,932 | −$26.15K |
| 2026-03-11 | David Harse | General Manager Patient Care | F | −377 | −$6.96K |
| 2025-12-03 | Pinetree Capital Ltd. | 10%+ Owner | Buy | +260,000 | +$5.86M |
| 2025-11-20 | L6 Holdings Inc. | 10%+ Owner | Buy | +75,694 | +$1.55M |
| 2025-11-19 | L6 Holdings Inc. | 10%+ Owner | Buy | +65,694 | +$1.35M |
| 2025-11-18 | Michael Daughton | Chief Business Officer | Buy | +50,000 | +$999.17K |
| 2025-11-14 | Pinetree Capital Ltd. | 10%+ Owner | Buy | +97,806 | +$1.98M |
| 2025-10-15 | Michael Daughton | Chief Business Officer | A | +7,492 | — |
| 2025-08-15 | David Harse | General Manager Patient Care | Sell | −1,744 | −$47.79K |
| 2025-07-28 | Vita MacIntyre | Controller | Sell | −335 | −$8.35K |
| 2025-07-03 | Christopher L Fowler | President and CEO | F | −3,786 | −$69.43K |
| 2025-05-23 | L6 Holdings Inc. | 10%+ Owner | Buy | +140,000 | +$3.38M |
| 2025-05-23 | L6 Holdings Inc. | 10%+ Owner | Buy | +160,000 | +$3.86M |
| 2025-05-20 | Christopher L Fowler | President and CEO | Sell | −6,000 | −$150.30K |
| 2025-03-31 | Vita MacIntyre | Controller | F | −188 | −$5.36K |
| 2025-03-26 | Merideth Wilson | Financial Health GM | A | +7,440 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Pinetree Capital Ltd. | 10%+ Owner | 2,075,000 | $54.45M |
| Christopher L Fowler | President and CEO | 120,486 | $3.16M |
| David A Dye | Chief Operating Officer | 81,646 | $2.14M |
| Michael Daughton | Chief Business Officer | 59,315 | $1.56M |
| Vinay Bassi | Chief Financial Officer | 39,992 | $1.05M |
| Dawn M Severance | Chief Sales Officer | 30,595 | $802.81K |
| David Harse | General Manager Patient Care | 16,888 | $443.14K |
| Kevin Plessner | General Counsel | 12,460 | $326.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TBRG quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.